Doctors say they help. So why are COVID-19 treatments—including monoclonal antibodies, antivirals, and corticosteroids—going unused?
Less than 25% of available doses of monoclonal antibodies have been administered, for example. They must be given early, often before patients seek hospitalization, which has hampered their use.
The Main Hurdle: Delivery. Many treatments require medical supervision that strained hospitals cannot provide—underscoring the importance of reducing transmission.